RVNC - Revance Therapeutics files for mixed shelf
2023-11-14 17:52:57 ET
More on Revance Therapeutics
- Revance Therapeutics, Inc. (RVNC) Q3 2023 Earnings Call Transcript
- Revance Therapeutics: Impressive Sales Growth/Concerning Cash Burn
- Revance's FDA Nod: Beauty, Brains, And Balance Sheets
- Needham says Abbvie's Botox sales results good news for Evolus, Revance
- GLP-1 drugs may already be impacting aesthetics sector, survey finds
For further details see:
Revance Therapeutics files for mixed shelf